PMID- 32104025 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220413 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 13 DP - 2020 TI - Association Between Cognitive Impairment and Blood Pressure Among Patients with Type II Diabetes Mellitus in Southern Iran. PG - 289-296 LID - 10.2147/DMSO.S238247 [doi] AB - PURPOSE: Both type 2 diabetes mellitus (T2DM) and hypertension are regarded as life-threatening diseases known to be risk factors for vascular diseases. They may be associated with the increased risk of cognitive impairment (CI), although there are conflicting data relating hypertension to the risk of CI. Therefore, this study aimed to explore the probable association between hypertension and CI in patients with T2DM. PATIENTS AND METHODS: This cross-sectional study assessed the degree of CI of a total of 350 patients with T2DM using the Mini-Mental State Examination (MMSE). In clinical examinations, the mean of the first, second, and third measurements of systolic and diastolic blood pressure (SBP and DBP) was recorded. RESULTS: The mean of subjects' MMSE scores was 25.48 +/- 3.73. Additionally, the means of SBPSs and DBPs were found to be 118.50 +/- 17.27 and 73.47 +/- 10.25 mmHg, respectively. The Spearman correlation coefficient showed a mild, significant, negative correlation between MMSE scores and those of SBP (r = -0.199, p <0.001) and DBP (r = -0.233, p <0.001). Accordingly, a 1-unit increase in one's SBP would lead to a significant rise in mild CI (2.8%) in comparison with subjects who have normal CIs. However, it was shown that if one's DBP increased by 1 unit, the odds of mild CI occurring would increase significantly by 6.7% compared with those who have normal CIs. CONCLUSION: The present findings revealed that hypertension might be related to the development of CI in people with a diabetic condition, thus emphasizing the fact that the prevention and treatment of these highly prevalent diseases assume the utmost significance. CI - (c) 2020 Jamalnia et al. FAU - Jamalnia, Sheida AU - Jamalnia S AD - Medical Journalism Department, Shiraz University of Medical Sciences, Shiraz, Iran. FAU - Javanmardifard, Sorur AU - Javanmardifard S AD - School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. FAU - Akbari, Hamed AU - Akbari H AUID- ORCID: 0000-0002-9939-6652 AD - Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. AD - Department of Biochemistry, Afzalipur Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran. FAU - Sadeghi, Erfan AU - Sadeghi E AD - Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. AD - Department of Biostatistics and Epidemiology, Faculty of Health, Isfahan University of Medical Sciences, Isfahan, Iran. FAU - Bijani, Mostafa AU - Bijani M AD - Department of Medical Surgical Nursing, Fasa University of Medical Sciences, Fasa, Iran. LA - eng PT - Journal Article DEP - 20200205 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC7008183 OTO - NOTNLM OT - blood pressure OT - cognitive impairment OT - hypertension OT - type II diabetes mellitus COIS- The author reports no conflicts of interest in this work. EDAT- 2020/02/28 06:00 MHDA- 2020/02/28 06:01 PMCR- 2020/02/05 CRDT- 2020/02/28 06:00 PHST- 2019/11/12 00:00 [received] PHST- 2020/01/15 00:00 [accepted] PHST- 2020/02/28 06:00 [entrez] PHST- 2020/02/28 06:00 [pubmed] PHST- 2020/02/28 06:01 [medline] PHST- 2020/02/05 00:00 [pmc-release] AID - 238247 [pii] AID - 10.2147/DMSO.S238247 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2020 Feb 5;13:289-296. doi: 10.2147/DMSO.S238247. eCollection 2020.